Related references
Note: Only part of the references are listed.COMPare: a prospective cohort study correcting and monitoring 58 misreported trials in real time
Ben Goldacre et al.
TRIALS (2019)
COMPare: Qualitative analysis of researchers' responses to critical correspondence on a cohort of 58 misreported trials
Ben Goldacre et al.
TRIALS (2019)
Feasibility of Using Real-World Data to Replicate Clinical Trial Evidence
Victoria L. Bartlett et al.
JAMA NETWORK OPEN (2019)
A mapping of 115,000 randomized trials revealed a mismatch between research effort and health needs in non high-income regions
Ignacio Atal et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2018)
The gendered system of academic publishing
Jamie Lundine et al.
LANCET (2018)
Data sharing and reanalysis of randomized controlled trials in leading biomedical journals with a full data sharing policy: survey of studies published in The BMJ and PLOS Medicine
Florian Naudet et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Data sharing and reanalysis of randomized controlled trials in leading biomedical journals with a full data sharing policy: survey of studies published in The BMJ and PLOS Medicine
Florian Naudet et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
When will clinical trials finally reflect diversity?
Todd C. Knepper et al.
NATURE (2018)
Self-citation is the hallmark of productive authors, of any gender
Shubhanshu Mishra et al.
PLOS ONE (2018)
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Spencer L. G. James et al.
LANCET (2018)
Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Hmwe Hmwe Kyu et al.
LANCET (2018)
Collaboration between academics and industry in clinical trials: cross sectional study of publications and survey of lead academic authors
Kristine Rasmussen et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Reproducible research practices, transparency, and open access data in the biomedical literature, 2015-2017
Oshua D. Wallach et al.
PLOS BIOLOGY (2018)
Association of the FDA Amendment Act with trial registration, publication, and outcome reporting
Adam T. Phillips et al.
TRIALS (2017)
Evolution of poor reporting and inadequate methods over time in 20 920 randomised controlled trials included in Cochrane reviews: research on research study
Agnes Dechartres et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Evolution of poor reporting and inadequate methods over time in 20 920 randomised controlled trials included in Cochrane reviews: research on research study
Agnes Dechartres et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Vicious circles of gender bias, lower positions, and lower performance: Gender differences in scholarly productivity and impact
Peter van den Besselaar et al.
PLOS ONE (2017)
Reporting of statistically significant results at ClinicalTrials.gov for completed superiority randomized controlled trials
Agnes Dechartres et al.
BMC MEDICINE (2016)
Quantifying the economic impact of government and charity funding of medical research on private research and development funding in the United Kingdom
Jon Sussex et al.
BMC MEDICINE (2016)
Randomized trials are frequently fragmented in multiple secondary publications
Shanil Ebrahim et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2016)
Increasing value and reducing waste in biomedical research: who's listening?
David Moher et al.
LANCET (2016)
Trial Reporting in ClinicalTrials.gov - The Final Rule
Deborah A. Zarin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Are citations from clinical trials evidence of higher impact research? An analysis of ClinicalTrials.gov
Mike Thelwall et al.
SCIENTOMETRICS (2016)
Reporting quality of randomised controlled trial abstracts among high-impact general medical journals: a review and analysis
Meredith Hays et al.
BMJ OPEN (2016)
Trends and comparison of female first authorship in high impact medical journals: observational study (1994-2014)
Giovanni Filardo et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Sharing Clinical Trial Data: A Proposal from the International Committee of Medical Journal Editors
Darren B. Taichman et al.
PLOS MEDICINE (2016)
Trends and comparison of female first authorship in high impact medical journals: observational study (1994-2014)
Giovanni Filardo et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
The Anatomy of Medical Research US and International Comparisons
Hamilton Moses et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Association between randomised trial evidence and global burden of disease: cross sectional study (Epidemiological Study of Randomized Trials-ESORT)
Connor A. Emdin et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Meta-research: Evaluation and Improvement of Research Methods and Practices
John P. A. Ioannidis et al.
PLOS BIOLOGY (2015)
Association between randomised trial evidence and global burden of disease: cross sectional study (Epidemiological Study of Randomized Trials-ESORT)
Connor A. Emdin et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Randomised trials in developing countries
James A. Berkley
ARCHIVES OF DISEASE IN CHILDHOOD (2014)
Global collaborative networks on meta-analyses of randomized trials published in high impact factor medical journals: a social network analysis
Ferran Catala-Lopez et al.
BMC MEDICINE (2014)
Reporting of Results in ClinicalTrials.gov and High-Impact Journals
Jessica E. Becker et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
How to increase value and reduce waste when research priorities are set
Iain Chalmers et al.
LANCET (2014)
Measuring the impact of methodological research: a framework and methods to identify evidence of impact
Valerie C. Brueton et al.
TRIALS (2014)
SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials
An-Wen Chan et al.
ANNALS OF INTERNAL MEDICINE (2013)
Mapping of available health research and development data: what's there, what's missing, and what role is there for a global observatory?
John-Arne Rottingen et al.
LANCET (2013)
Systematic Review of the Empirical Evidence of Study Publication Bias and Outcome Reporting Bias - An Updated Review
Kerry Dwan et al.
PLOS ONE (2013)
Citation Classics in Systematic Reviews and Meta-Analyses: Who Wrote the Top 100 Most Cited Articles?
Olalekan A. Uthman et al.
PLOS ONE (2013)
Getting the Methods Right - The Foundation of Patient-Centered Outcomes Research
Sherine E. Gabriel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Assessment of adherence to the CONSORT statement for quality of reports on randomized controlled trial abstracts from four high-impact general medical journals
Saurav Ghimire et al.
TRIALS (2012)
Magnitude of effects in clinical trials published in high-impact general medical journals
Konstantinos C. M. Siontis et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2011)
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Paul B. Chapman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Public Availability of Published Research Data in High-Impact Journals
Alawi A. Alsheikh-Ali et al.
PLOS ONE (2011)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
Kenneth F. Schulz et al.
TRIALS (2010)
Does the development of new medicinal products in the European Union address global and regional health concerns?
Ferran Catala-Lopez et al.
POPULATION HEALTH METRICS (2010)
Reporting of Safety Results in Published Reports of Randomized Controlled Trials
Isabelle Pitrou et al.
ARCHIVES OF INTERNAL MEDICINE (2009)
Comparison of Registered and Published Primary Outcomes in Randomized Controlled Trials
Sylvain Mathieu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Dabigatran versus Warfarin in Patients with Atrial Fibrillation.
Stuart J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
How citation distortions create unfounded authority: analysis of a citation network
Steven A. Greenberg
BMJ-BRITISH MEDICAL JOURNAL (2009)
Reporting of sample size calculation in randomised controlled trials: review
Pierre Charles et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Reporting and interpretation of SF-36 outcomes in randomised trials: systematic review
Despina G. Contopoulos-Ioannidis et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Falsified papers in high-impact journals were slow to retract and indistinguishable from nonfraudulent papers
Nikolaos A. Trikalinos et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Effects of intensive glucose lowering in type 2 diabetes
Hertzel C. Gerstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Trial registration at ClinicalTrials.Gov between May and October 2005
DA Zarin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Contradicted and initially stronger effects in highly cited clinical research
JPA Ioannidis
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Optimal search strategies for retrieving scientifically strong studies of treatment from Medline: analytical survey
RB Haynes et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
H Hurwitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Risks and benefits of estrogen plus progestin in healthy postmenopausal women - Principal results from the Women's Health Initiative randomized controlled trial
JE Rossouw et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial
R Collins et al.
LANCET (2002)
Relation between burden of disease and randomised evidence in sub-Saharan Africa: survey of research
P Isaakidis et al.
BRITISH MEDICAL JOURNAL (2002)
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
WC Knowler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
BM Brenner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.
J Tuomilehto et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
The CONSORT statement: Revised recommendations for improving the quality of reports of parallel-group randomized trials
D Moher et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
DJ Slamon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)